Effects of Ninjin’yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial

References

• Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chronic Obstr Pulmon Dis. 2014;9:871–888. doi:10.2147/COPD.S49621
   PubMed Web of Science ®Google Scholar
• Marengoni A, Vetrano DL, Manes-Gravina E, Bernabei R, Onder G, Palmer K; The Relationship Between COPD and frailty. A systematic review and meta-analysis of observational studies. Chest. 2018;154(1):21–40. doi:10.1016/j.chest.2018.02.014
   PubMed Web of Science ®Google Scholar
• Benz E, Trajanoska K, Lahousse L, et al. Sarcopenia in COPD: a systematic review and meta-analysis. Eur Respir Rev. 2019;28(154):190049. doi:10.1183/16000617.0049-2019
   PubMed Web of Science ®Google Scholar
• Bone AE, Hepgul N, Kon S, Maddocks M. Sarcopenia and frailty in chronic respiratory disease. Chronic Respir Dis. 2017;14(1):85–99. doi:10.1177/1479972316679664
   PubMed Web of Science ®Google Scholar
• Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010;36(1):81–88. doi:10.1183/09031936.00104909
   PubMed Web of Science ®Google Scholar
• Natanek SA, Gosker HR, Slot IG, et al. Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratified medicine? Muscle Nerve. 2013;48(4):488–497. doi:10.1002/mus.23784
   PubMed Web of Science ®Google Scholar
• Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007;62(2):115–120. doi:10.1136/thx.2006.062026
   PubMed Web of Science ®Google Scholar
• Beckwée D, Delaere A, Aelbrecht S, et al. Exercise interventions for the prevention and treatment of sarcopenia. A systematic umbrella review. J Nutr Health Aging. 2019;23(6):494–502. doi:10.1007/s12603-019-1196-8
   PubMed Web of Science ®Google Scholar
• Jones SE, Maddocks M, Kon SSC. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax. 2015;70(3):213–218. doi:10.1136/thoraxjnl-2014-206440
   PubMed Web of Science ®Google Scholar
• Finamore P, Scarlata S, Delussu AS, Traballesi M, Incalzi RA, Laudisio A. Frailty Impact during and after Pulmonary Rehabilitation. COPD. 2021;18(5):518–524. doi:10.1080/15412555.2021.1967915
   PubMedGoogle Scholar
• Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;12:CD000998. doi:10.1002/14651858.CD000998.pub3
   PubMed Web of Science ®Google Scholar
• Ali S, Garcia JM. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - A mini-review. Gerontology. 2014;60(4):294–305. doi:10.1159/000356760
   PubMed Web of Science ®Google Scholar
• Sato S. Apathy and fatigue in autistic spectrum disorder improved by Japanese herbal medicine: TSUMURA Ninjin’yoeito extract. Psychiatry Clin Neurosci. 2018;72(7):540. doi:10.1111/pcn.12667
   PubMed Web of Science ®Google Scholar
• Xu Y, Chen Y, Li P, Wang XS. Ren Shen Yangrong Tang for Fatigue in cancer survivors: a Phase I/II Open-Label Study. J Altern Complement Med. 2015;21(5):281–287. doi:10.1089/acm.2014.0211
   PubMed Web of Science ®Google Scholar
• Ishiura Y, Shiba Y, Terasaki Y, et al. 非小細胞肺癌外来化学療法患者のQOL に対する人参養栄湯の効果 [Effect of Japanese Traditional Medicine, Ninjin-Youei-To (TJ-108), on the Quality of Life of Patients with Non-Small Cell Lung Cancer Receiving Outpatient Chemotherapy]. Gan to Kagaku Ryoho. 2018;45:1071–1074. Japanese.
   PubMedGoogle Scholar
• Goswami C, Dezaki K, Wang L, Inui A, Seino Y, Yada T. Ninjin-yoeito activates ghrelin-responsive and unresponsive NPY neurons in the arcuate nucleus and counteracts cisplatin-induced anorexia. Neuropeptides. 2019;75:58–64. doi:10.1016/j.npep.2019.03.001
   PubMed Web of Science ®Google Scholar
• Miyamoto A, Asai K, Kadotani H, et al. Ninjin’yoeito ameliorates skeletal muscle complications in COPD model mice by upregulating peroxisome proliferator-activated receptor γ Coactivator-1α expression. Int J Chronic Obstr Pulm Dis. 2020;15:3063–3077. doi:10.2147/COPD.S280401
   PubMed Web of Science ®Google Scholar
• Puente-Maestu L, Pérez-Parra J, Godoy R, et al. Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients. Eur Respir J. 2009;33(5):1045–1052. doi:10.1183/09031936.00112408
   PubMed Web of Science ®Google Scholar
• Jobin J, Maltais F, Doyon JF, et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehabil. 1998;18(6):432–437. doi:10.1097/00008483-199811000-00005
   PubMedGoogle Scholar
• Koves TR, Li P, An J, et al. Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem. 2005;280(39):33588–33598. doi:10.1074/jbc.M507621200
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
   PubMed Web of Science ®Google Scholar
• Kitamura T. Hospital Anxiety and Depression Scale (Hads). Arch Psychiatr Diagn Clin Eval. 1993;4:371–372. Japanese.
   Google Scholar
• Wilson MM, Thomas DR, Rubenstein LZ, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82(5):1074–1081. doi:10.1093/ajcn/82.5.1074
   PubMed Web of Science ®Google Scholar
• Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101. doi:10.1016/j.jamda.2013.11.025
   PubMed Web of Science ®Google Scholar
• Kon SS, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203. doi:10.1016/S2213-2600(14)70001-3
   PubMed Web of Science ®Google Scholar
• Araújo Oliveira AL, Andrade L, Marques A. Minimal clinically important difference and predictive validity of the mMRC and mBorg in acute exacerbations of COPD. Eur Respir J. 2017;50(Suppl 61):PA4705.
   Google Scholar
• Cazzola M, Hanania NA, MacNee W, Rüdell K, Hackford C, Tamimi N. A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges. Int J Chronic Obstr Pulm Dis. 2015;10:725–738. doi:10.2147/COPD.S77368
   PubMed Web of Science ®Google Scholar
• Puhan MA, Frey M, Büchi S, Schünemann HJ. The minimal important difference of the Hospital Anxiety and Depression Scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2008;6:46. doi:10.1186/1477-7525-6-46
   PubMed Web of Science ®Google Scholar
• Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342. doi:10.1378/chest.10-2521
   PubMed Web of Science ®Google Scholar
• Furlanetto KC, Donária L, Schneider LP, et al. Sedentary behavior is an independent predictor of mortality in subjects with COPD. Respir Care. 2017;62(5):579–587. doi:10.4187/respcare.05306
   PubMed Web of Science ®Google Scholar
• Gouzi F, Préfaut C, Abdellaoui A, et al. Evidence of an early physical activity reduction in chronic obstructive pulmonary disease patients. Arch Phys Med Rehabil. 2011;92(10):1611–1617. e2. doi:10.1016/j.apmr.2011.05.012
   PubMed Web of Science ®Google Scholar
• Hirai K, Homma T, Matsunaga T, et al. Usefulness of Ninjin’yoeito for chronic obstructive pulmonary disease patients with frailty. J Altern Complement Med. 2020;26(8):750–757. doi:10.1089/acm.2020.0083
   PubMed Web of Science ®Google Scholar
• Tatsumi K, Shinozuka N, Nakayama K, Sekiya N, Kuriyama T, Fukuchi Y. Hochuekkito improves systemic inflammation and nutritional status in elderly patients with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2009;57(1):169–170. doi:10.1111/j.1532-5415.2009.02034.x
   PubMed Web of Science ®Google Scholar
• Hamada H, Sekikawa K, Murakami I, et al. Effects of Hochuekkito combined with pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Exp Ther Med. 2018;16(6):5236–5242. doi:10.3892/etm.2018.6837
   PubMed Web of Science ®Google Scholar
• Swallow EB, Barreiro E, Gosker H, et al.; ENIGMA in COPD project. Quadriceps muscle strength in scoliosis. Eur Respir J. 2009;34(6):1429–1435. doi:10.1183/09031936.00074008
   PubMed Web of Science ®Google Scholar